Prof. Andrew Scott is Laboratory Head at the Olivia Newton-John Cancer Research Institute; Director, Department of Molecular Imaging and Therapy, Austin Health; and Professor, University of Melbourne, La Trobe University, and Monash University. His clinical and research interests are focused on developing innovative strategies for targeted therapy of cancer with monoclonal antibodies, and in molecular imaging particularly oncology applications in PET in staging cancer. His laboratory has been involved in the preclinical development and first-in-man trials of numerous recombinant antibodies in cancer patients, and five antibodies developed in his laboratory have been licensed to Biotech and Pharma companies. He has served on numerous Government and International advisory committees, not-for-profit Boards, and journal Editorial Boards. Prof. Scott has published 340 peer reviewed papers and 22 book chapters, principally in the areas of oncology and molecular imaging.
Employee Spotlight: Dan Inglese, Research Associate
April 12, 2022
Highlighting our dedicated employees who bring both their experience and passions to Imagion Biosystems: What experience do you bring prior to joining IB? I